The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
methyl 2-[(4-oxo-1-phenyl-5H-pyrazolo[3,4-d]pyrimidin-6-yl)methoxy]benzoate ID: ALA4790850
PubChem CID: 162671385
Max Phase: Preclinical
Molecular Formula: C20H16N4O4
Molecular Weight: 376.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)c1ccccc1OCc1nc2c(cnn2-c2ccccc2)c(=O)[nH]1
Standard InChI: InChI=1S/C20H16N4O4/c1-27-20(26)14-9-5-6-10-16(14)28-12-17-22-18-15(19(25)23-17)11-21-24(18)13-7-3-2-4-8-13/h2-11H,12H2,1H3,(H,22,23,25)
Standard InChI Key: OFDUSMVPGGANBN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
11.7899 -6.4770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0780 -6.8874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0780 -7.7120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7935 -8.1181 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4980 -7.7086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4980 -6.8866 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2171 -8.1228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9303 -7.7086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6476 -8.1228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3629 -7.7090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0769 -8.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0769 -8.9467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3666 -9.3594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6477 -8.9483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3629 -6.8807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6463 -6.4705 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0796 -6.4705 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0796 -5.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2958 -7.9695 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8099 -7.3016 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2959 -6.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0768 -8.7664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2788 -8.9813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0677 -9.7798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6521 -10.3578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4537 -10.1447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6628 -9.3471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7899 -5.6487 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
4 3 1 0
5 4 2 0
6 5 1 0
1 6 1 0
7 5 1 0
7 8 1 0
8 9 1 0
10 9 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
10 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
3 19 1 0
19 20 1 0
20 21 2 0
2 21 1 0
22 19 1 0
22 23 1 0
24 23 2 0
25 24 1 0
26 25 2 0
27 26 1 0
27 22 2 0
1 28 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 376.37Molecular Weight (Monoisotopic): 376.1172AlogP: 2.47#Rotatable Bonds: 5Polar Surface Area: 99.10Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.73CX Basic pKa: ┄CX LogP: 2.47CX LogD: 2.45Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.54Np Likeness Score: -1.67
References 1. Shaaban MA,Elshaier YAMM,Hammad AH,Farag NA,Hassan Haredy H,AbdEl-Ghany AA,Mohamed KO. (2020) Design and synthesis of pyrazolo[3,4-d]pyrimidinone derivatives: Discovery of selective phosphodiesterase-5 inhibitors., 30 (16): [PMID:32631538 ] [10.1016/j.bmcl.2020.127337 ]